In the CSF, higher fractions of activated CD4+ and CD8+ Tc as well as Bc were shared between RRMS and IDH-WT glioma patients in comparison to SD controls (Fig. 1B, P, R, U). The gene discussed is CD4; the disease is central nervous system cancer.